GlySure
Continuous intravascular glucose monitoring system for tight glycemic control (TGC) in the hospital
GlySure has raised €19M across 2 funding rounds from 2 investors, most recently a Series C round in Nov 2012. Based in UK; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€19M
€18,847,398
Funding rounds
2
Investors
2
distinct backers
Active since
2012-01
latest 2012-11
Funding by year
EUR raised per yearGlySure — funding by year — interactive chart.
Data table
| GlySure — funding by year | |
|---|---|
| 2011 | €8.4M |
| 2012 | €10M |
Signals
High confidenceRaise-next likelihood11
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood5
base rate 11% (2+ rounds)
- ▼ Old (20y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-11-01 | Series C | €10M | Amadeus Capital Partners,Delta Partners | View deal → |
| 2012-01-01 | Series C | €8.4M | Amadeus Capital Partners,Delta Partners | View deal → |